Mitochondrial disorder with OPA1 mutation lacking optic atrophy

Mitochondrion

Volumn 9, Issue 4, 2009, Pages 279-281

  Milone, Margherita ^a   Younge, Brian R ^a   Wang, Jing ^b   Zhang, Shulin ^b   Wong, Lee Jun ^b  

^a MAYO CLINIC   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Mitochondrial disorder; OPA1; Optic atrophy

Indexed keywords

CYTOCHROME C OXIDASE; EYE PROTEIN; MITOCHONDRIAL DNA; OPTIC ATROPHY TYPE 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FAMILY HISTORY; FATIGUE; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; OPHTHALMOPLEGIA; OPTIC NERVE ATROPHY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PTOSIS;

DNA, MITOCHONDRIAL; FEMALE; GTP PHOSPHOHYDROLASES; HUMANS; MIDDLE AGED; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; OPTIC ATROPHY; SEQUENCE DELETION;

EID: 67349118193     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2009.03.001     Document Type: Article

References (10)

1. Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., Bhattacharya S.S., and Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26 (2000) 211-215
2. Amati-Bonneau P., Valentino M.L., Reynier P., Gallardo M.E., Bornstein B., Boissiere A., Campos Y., Rivera H., de la Aleja J.G., Carroccia R., Iommarini L., Labauge P., Figarella-Branger D., Marcorelles P., Furby A., Beauvais K., Letournel F., Liguori R., La Morgia C., Montagna P., Liguori M., Zanna C., Rugolo M., Cossarizza A., Wissinger B., Verny C., Schwarzenbacher R., Martin M.A., Arenas J., Ayuso C., Garesse R., Lenaers G., Bonneau D., and Carelli V. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 131 (2008) 338-351
3. Cornille K., Milea D., Amati-Bonneau P., Procaccio V., Zazoun L., Guillet V., El Achouri G., Delettre C., Gueguen N., Loiseau D., Muller A., Ferre M., Chevrollier A., Wallace D.C., Bonneau D., Hamel C., Reynier P., and Lenaers G. Reversible optic neuropathy with OPA1 exon 5b mutation. Ann. Neurol. 63 (2008) 667-671
4. Delettre C., Lenaers G., Griffoin J.M., Gigarel N., Lorenzo C., Belenguer P., Pelloquin L., Grosgeorge J., Turc-Carel C., Perret E., Astarie-Dequeker C., Lasquellec L., Arnaud B., Ducommun B., Kaplan J., and Hamel C.P. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26 (2000) 207-210
5. Hudson G., Amati-Bonneau P., Blakely E.L., Stewart J.D., He L., Schaefer A.M., Griffiths P.G., Ahlqvist K., Suomalainen A., Reynier P., McFarland R., Turnbull D.M., Chinnery P.F., and Taylor R.W. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131 (2008) 329-337
6. Payne M., Yang Z., Katz B.J., Warner J.E., Weight C.J., Zhao Y., Pearson E.D., Treft R.L., Hillman T., Kennedy R.J., Meire F.M., and Zhang K. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am. J. Ophthalmol. 138 (2004) 749-755
7. Stewart J.D., Hudson G., Yu-Wai-Man P., Blakeley E.L., He L., Horvath R., Maddison P., Wright A., Griffiths P.G., Turnbull D.M., Taylor R.W., and Chinnery P.F. OPA1 in multiple mitochondrial DNA deletion disorders. Neurology 71 (2008) 1829-1831
8. Thiselton D.L., Alexander C., Taanman J.W., Brooks S., Rosenberg T., Eiberg H., Andreasson S., Van Regemorter N., Munier F.L., Moore A.T., Bhattacharya S.S., and Votruba M. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1715-1724
9. Votruba M., Fitzke F.W., Holder G.E., Carter A., Bhattacharya S.S., and Moore A.T. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch. Ophthalmol. 116 (1998) 351-358
10. Zeviani M. OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. Brain 131 (2008) 314-317